NDC 71863-212

REZIPRES

Ephedrine Hydrochloride

REZIPRES is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eton Pharmaceuticals, Inc.. The primary component is Ephedrine Hydrochloride.

Product ID71863-212_2ed4c742-ab6c-484c-8243-0283aad354cd
NDC71863-212
Product TypeHuman Prescription Drug
Proprietary NameREZIPRES
Generic NameEphedrine Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-06-14
Marketing CategoryNDA /
Application NumberNDA213536
Labeler NameEton Pharmaceuticals, Inc.
Substance NameEPHEDRINE HYDROCHLORIDE
Active Ingredient Strength47 mg/mL
Pharm Classesalpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Drug Details

NDC Crossover Matching brand name "REZIPRES" or generic name "Ephedrine Hydrochloride"

NDCBrand NameGeneric Name
39822-1410REZIPRESEphedrine hydrochloride
71863-210REZIPRESEphedrine hydrochloride
71863-211REZIPRESEphedrine hydrochloride
71863-212REZIPRESEphedrine hydrochloride
0363-9812Ephedrine HydrochlorideEphedrine Hydrochloride
80070-600PrimateneEPHEDRINE HYDROCHLORIDE
71952-030Rinosan MINT Nasal DecongestantEPHEDRINE HYDROCHLORIDE
73061-001Rinosan Mint Nasal DecongestantEPHEDRINE HYDROCHLORIDE
71952-040Rinosan PROPO Nasal DecongestantEPHEDRINE HYDROCHLORIDE
73061-002Rinosan Propo Nasal DecongestantEPHEDRINE HYDROCHLORIDE

Trademark Results [REZIPRES]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REZIPRES
REZIPRES
90060774 not registered Live/Pending
Eton Pharmaceuticals, Inc.
2020-07-19
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.